Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Centre, Randomised, Controlled Trial of Hyperfractionated IMRT and Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.

NCT02456506 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT02456506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02456506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Centre, Randomised, Controlled Trial of Hyperfractionated IMRT and Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.
Lead sponsor
Sun Yat-sen University
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2015
Completion date
March 31, 2023
Enrollment
142 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complications, mortality, nasopharyngeal neoplasms, quality of life